Over the past year, AlphaEvolve (DeepMind) and DeepEvolve (Liu et al.) have taken on one of science’s most audacious challenges: can machines not only execute discovery but originate it? Both leverage large language models (LLMs) to iteratively evolve algorithms through feedback and automated evaluation.

AlphaEvolve reframed discovery as code evolution: LLMs proposing edits, testing them, and optimizing against performance scores. DeepEvolve extends this paradigm by integrating deep research: literature retrieval, structured reasoning, multi-file implementation, and automatic debugging. Together, they signal a shift from code-writing tools to more active scientific collaborators and raise foundational questions about what counts as “understanding.”

Scientific Insight

AlphaEvolve’s achievements are real and impressive: it discovered a novel algorithm for 4×4 matrix multiplication, improving on a benchmark that had stood since 1969. But its limitations are equally instructive. When optimization is tethered entirely to scalar reward signals, models risk learning how to perform rather than how to understand.

DeepEvolve addresses some of this by incorporating retrieval-augmented reasoning and grounded iteration, showing measurable gains across nine domains—from molecular property prediction to polymer engineering. Yet the deeper challenge persists: these systems can refine heuristics, but they cannot yet articulate principles; the boundary between discovery and reward chasing remains unresolved.

Leadership Angle

For R&D leaders in life sciences or diagnostics, these systems are both technical achievements and strategic case studies.

Peter Drucker once warned: “What gets measured gets managed—even when it’s pointless to measure or manage it.” In the context of these papers, the risk is clear: if we measure only performance, we may optimize into blind alleys. The opportunity lies in designing systems (and organizations!) that ask better questions, not just produce better scores.

More in this series

  1. ChatNT: The future of biological assistants—or a mirage in a lab coat?
  2. GET: A Foundation Model for Transcription, Still Between Promise and Proof
  3. X-Atlas/Orion: Your Model is Only as Good as Your Training Data
  4. From Better Models to Better Questions: A Pathology AI Rethink
  5. The Model Isn’t the Magic: How Cytoland shows that domain expertise—not just deep learning—is what makes AI in biology work.
  6. Boltz-2: How much can 3D structure really tell us about molecular binding energetics?
  7. Investigating the volume and diversity of data needed for generalizable antibody–antigen ΔΔG prediction
  8. Beyond Binding: Rethinking Drug Design in the Age of AI and Structural Biology
  9. Testing the Physics Beneath the Predictions Beyond RMSD: What AlphaFold3 Really Understands
  10. Hype, Hurdles, and Hepatotoxicity: A Bold Step for AI-Designed Drugs, But Still Miles to Go
  11. When Complexity Misleads
  12. What Are Genomic Transformers Actually Learning?
  13. mRNABench and the Future of AI in Biology: Why Domain Knowledge Wins
  14. OncoGAN Creates Synthetic Cancer Genomes, Opening New Paths for Privacy-Preserving Precision Oncology
  15. Readable Rules, Testable Models: A New Grammar for Virtual Cells
  16. Multimodal CustOmics: Fusing Pathology Images and Tumor Genomics for Next-Gen Cancer Diagnostics
  17. Beyond Perturbation Simulations: PDGrapher Shows a Faster Way to Identify Actionable Targets
  18. Can AI design epigenetic anti-aging strategies?
  19. What happens when physicians use GPT-4 for diagnosis
  20. Can generative AI predict emergent phenomena?
  21. DeepSomatic and the question of how AI learns from itself
  22. Toward Mechanism-Centric Interpretability in Genomic Machine Learning
  23. From AlphaEvolve to DeepEvolve: What We’re Learning About Machine-Led Scientific Discovery
  24. Kosmos and the Culture of Discovery
  25. From Embeddings to Insight
  26. From Prediction to Explanation: How BIOREASON Reframes Genomic AI as a Reasoning Problem
  27. AI Models Need Better Truth—Platinum Pedigree Shows How
  28. From Evolutionary Intolerance to Clinical Insight: What popEVE Teaches Us About Missense Variants
  29. Interpretable Latent Spaces, Messy Biology: What AUTOENCODIX Teaches Us About Autoencoders in the Wild
  30. The Gene Ontology Knowledgebase in 2026

Mentorship Angle

For early-career scientists, the message isn’t to fear or avoid these tools (please don’t, these tools are amazing!), but to understand their limitations. AlphaEvolve and DeepEvolve can automate exploration, but perhaps not judgment. They can generate thousands of hypotheses in hours, but still depend on human insight to distinguish signal from noise. And require careful thought in setting up reward systems that uncover real meaning in the context you care about.

In a world where even machines can “research,” the defining trait of good science will be the discipline to ask whether improvement is meaningful, not just measurable. That’s the work of real discovery and no algorithm can evolve that for us (at least not yet!).